Form D · Biotechnology
AbSci Corp
Vancouver, WA · CIK 0001672688
Offering snapshot reported Mar 30, 2021 · SEC filing
- Reported sold
- $70M Offering amount: $70M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 19, 2020 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 30, 2021 | Amendment | $69,999,976 | $0vs Feb 26, 2021 | 14 | SEC filing |
| Mar 30, 2021 | Initial | $125,000,000 | No comparison | 24 | SEC filing |
| Feb 26, 2021 | Amendment | $69,999,976 | $5,000,000vs Oct 30, 2020 | 14 | SEC filing |
| Oct 30, 2020 | Initial | $64,999,976 | No comparison | 13 | SEC filing |
| Dec 19, 2019 | Initial | $10,360,013 | No comparison | 17 | SEC filing |
| Jun 8, 2018 | Initial | $12,000,000 | No comparison | 31 | SEC filing |
| Apr 21, 2016 | Initial | $3,661,572 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-379306
Source: Form D, filed Mar 30, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Phil Barish | Director, Executive |
| Eli Casdin | Director |
| Daniel Gold | Director |
| Zach Jonasson | Director |
| Shelley Klassen | Executive |
| V. Bryan Lawlis | Director |
| Bryan Lawlis | Director |
| Bryan Lawliss | Director |
| Ivana Magovcevic Liebisch | Director |
| Gustavo Mahler | Director |
| Sean Mc Clain | Director, Executive |
| Lawrence Mc Clure | Executive |
| Karen Mc Ginnis | Director |
| Amrit Nagpal | Director |
| Andreas Pihl | Director |
| Gregory Schiffman | Executive |
| Zach Zach Jonasson | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:Vancouver, WA, 98660